Literature DB >> 2184751

Management of hypertrophic cardiomyopathy.

R Hopf1, M Kaltenbach.   

Abstract

Therapy of hypertrophic cardiomyopathy aspires to reduce symptoms, increase exercise tolerance, retard or prevent disease progression, and improve prognosis. Medical treatment with calcium antagonists and suppression of rhythm disturbances with amiodarone seem to be most effective. In patients who show no improvement, surgical treatment must be considered.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2184751     DOI： 10.1146/annurev.me.41.020190.000451

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


  3 in total

Review 1.  Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks.

Authors:  U Ravens; M Wehr
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

2.  A Pregnancy with Severe Hypertrophic Obstructive Cardiomyopathy after Surgery for an Implantable Cardioverter Defibrillator: A Case Report and Literature Review.

Authors:  Takashi Mitsui; Hisashi Masuyama; Kentaro Ejiri; Kei Hayata; Hiroshi Ito; Yuji Hiramatsu
Journal:  Case Rep Obstet Gynecol       Date:  2016-10-18

3.  Obstetric hemorrhage in a case of hypertrophic obstructive cardiomyopathy with automatic implantable cardioverter defibrillator: Anaesthesia and intensive care management.

Authors:  Sandeep Kumar Mishra; Ravindra R Bhat; Jayaram Kavitha; Pankaj Kundra; Satyen Parida
Journal:  Anesth Essays Res       Date:  2016 Jan-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.